Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
    • Portal Login
    Semaglutide: Revolutionizing Diabetes and Obesity Treatment Amidst Challenges in India
    November 8, 2024

        Semaglutide: Revolutionizing Diabetes and Obesity Treatment Amidst Challenges in India Sub : Sci Sec :Health Why in News The drug Semaglutide, specifically under brand names like Ozempic and Wegovy, has garnered widespread attention globally due to its dual efficacy in managing type 2 diabetes and obesity. Although its injectable form has made headlines […]

    Posted in: DPN Topics ,
    Tags: Science and tech , Semaglutide: Revolutionizing Diabetes and Obesity Treatment Amidst Challenges in India ,

    Recent Posts

    • Daily Prelims Notes 23 March 2025 March 23, 2025
    • Challenges in Uploading Voting Data March 23, 2025
    • Fertilizers Committee Warns Against Under-Funding of Nutrient Subsidy Schemes March 23, 2025
    • Tavasya: The Fourth Krivak-Class Stealth Frigate Launched March 23, 2025
    • Indo-French Naval Exercise Varuna 2024 March 23, 2025
    • No Mismatch Between Circulating Influenza Strains and Vaccine Strains March 23, 2025
    • South Cascade Glacier March 22, 2025
    • Made-in-India Web Browser March 22, 2025
    • Charting a route for IORA under India’s chairship March 22, 2025
    • Mar-a-Lago Accord and dollar devaluation March 22, 2025
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search